PDS Biotechnology Corp
SEC CIK 1472091 · PDSB · last insider filing 2026-03-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Brawley Otis W | Director | filed 2020–2026 |
| Glover Steve C | Director | filed 2019–2026 |
| Freitag Gregory Gene | Director | filed 2019–2026 |
| Ali-Jackson Kamil | Director | filed 2020–2026 |
| Bedu-Addo Frank | Director · President/CEO | filed 2019–2026 |
| Iliev Ilian | Director | filed 2020–2026 |
| Sykes Richard | Director | filed 2019–2024 |
| Bloomquist Delyle W | Director | filed 2019–2021 |
| Saik Andrew | Director · Chief Financial Officer | filed 2017–2020 |
| Loughlin James J | Director | filed 2015–2019 |
| Barer SOL J | Director | filed 2015–2019 |
| Crane Rosemary A | Director | filed 2017–2019 |
| Spiegel Robert J. | Director | filed 2015–2019 |
| Ratcliffe Liam | Director | filed 2016–2019 |
| Leuthner Brian A | Director · President and CEO | filed 2015–2019 |
| Macdonald R. Loch | Director · Chief Scientific Officer | filed 2015–2019 |
| Blech Isaac | Director | filed 2015–2019 |
| Conti Kurt G | Director | filed 2015–2018 |
| Healy James | Director | filed 2015–2017 |
| New Leaf Ventures III, L.P. | Director | filed 2016–2016 |
| New Leaf Venture Associates III, L.P. | Director | filed 2016–2016 |
| New Leaf Venture Management III, L.L.C. | Director | filed 2016–2016 |
| New Leaf Venture Partners, L.L.C. | Director | filed 2016–2016 |
| Hove Anders D | Director | filed 2015–2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Boesgaard Lars | Chief Financial Officer | filed 2023–2026 |
| Toutain Stephan | Chief Operations Officer | filed 2024–2026 |
| Conn Gregory | Chief Scientific Officer | filed 2019–2026 |
| Brown Spencer D. | Senior VP, General Counsel | filed 2022–2026 |
| Shepard Kirk V. | Chief Medical Officer | filed 2024–2026 |
| Hill Matthew C | Chief Financial Officer | filed 2021–2023 |
| Wood Lauren | Chief Medical Officer | filed 2019–2023 |
| Trochimiuk Janetta | Principal Accounting Officer | filed 2020–2021 |
| VAN Voorhees Seth | Chief Financial Officer | filed 2021–2021 |
| King Michael N. | Interim Chief Financial Office | filed 2020–2020 |
| Middlekauff W Bradford | Senior VP, GC and Secretary | filed 2015–2019 |
| Wyant Alyssa | SVP Regulatory Affairs | filed 2017–2019 |
| Marchio Albert N II | Chief Acct. & Op., Asst. Sec. | filed 2015–2018 |
| Faleck Herbert J | Chief Medical Officer | filed 2015–2018 |
| Brennan Daniel | Chief Operating Officer | filed 2016–2018 |
| Yaman Alpaslan | Vice Pres., Tech. Op. & Manu. | filed 2015–2017 |
| Einhorn Andrew J. | Chief Financial Officer | filed 2015–2017 |
| Vaish Renu | V.P., Global Reg. Affairs | filed 2015–2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.